SCHEMBL20205624

SCHEMBL20205624

c1ccc2c(c1)-c1ccccc1C21c2cc3c(cc2-c2c1cc(-c1ccc4c(c1)oc1ccc5ccccc5c14)c1oc4ccccc4c21)C1(c2ccccc2-c2ccccc21)c1cc(-c2ccc4c(c2)oc2ccc5ccccc5c24)c2oc4ccccc4c2c1-3

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TDP1 Q9NUW8 4/20 0.36
▸ L3MBTL1 Q9Y468 2/20 0.36
▸ ABCG2 Q9UNQ0 5/20 0.34
▸ AHR P35869 2/20 0.34
▸ PAX8 Q06710 2/20 0.34
▸ CYP1A1 P04798 1/20 0.34
▸ CYP1A2 P05177 1/20 0.34
▸ FYN P06241 1/20 0.34
▸ MAPK3 P27361 1/20 0.34
▸ ALOX5 P09917 1/20 0.33
▸ PRKDC P78527 1/20 0.32
▸ KMT2A Q03164 2/20 0.32
▸ NPC1 O15118 2/20 0.32
▸ MAPT P10636 2/20 0.32
▸ RAB9A P51151 1/20 0.32
▸ MEN1 O00255 1/20 0.32
▸ TP53 P04637 1/20 0.32
▸ CYP3A4 P08684 1/20 0.32
▸ CYP2D6 P10635 1/20 0.32
▸ CYP2C9 P11712 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20205655 0.92 ALOX5 (0.39) L3MBTL1AHRALOX5PRKDCKMT2A
SCHEMBL20205633 0.91 ALOX5 (0.35) AHRALOX5PRKDCKMT2AMAPT
SCHEMBL20205380 0.89 GPR84 (0.36) TDP1L3MBTL1CYP1A1CYP1A2ALOX5
SCHEMBL20205377 0.87 ALOX5 (0.36) TDP1L3MBTL1CYP1A2ALOX5RAB9A
SCHEMBL20205638 0.86 TDP1 (0.37) TDP1L3MBTL1ABCG2AHRPAX8
SCHEMBL20205334 0.84 CDC14B (0.37) L3MBTL1ABCG2ALOX5KMT2ANPC1
SCHEMBL20205383 0.83 ALOX5 (0.36) TDP1L3MBTL1CYP1A2ALOX5PRKDC
SCHEMBL20205579 0.83 TDP1 (0.34) TDP1L3MBTL1ABCG2AHRPAX8
SCHEMBL20205652 0.82 ALOX5 (0.30) ALOX5
SCHEMBL20205592 0.82 TDP1 (0.36) TDP1L3MBTL1ABCG2AHRPAX8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11453680-B2 Bisbenzofuran-fused indeno[1,2-B]fluorene derivatives and related compounds as materials for organic electroluminescent devices (OLED) MERCK PATENT GMBH (DE) 2022-09-27 — — US disclosed
EP-3544985-B1 BISBENZOFURAN-FUSED INDENO[1,2-B]FLUORENE DERIVATIVES AND RELATED COMPOUNDS AS MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES (OLED) MERCK PATENT GMBH (DE) 2021-05-12 — — EP disclosed
WO-2018095940-A1 BISBENZOFURAN-FUSED INDENO[1,2-B]FLUORENE DERIVATIVES AND RELATED COMPOUNDS AS MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES (OLED) MERCK PATENT GMBH (DE) 2018-05-31 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11453680-B2 Bisbenzofuran-fused indeno[1,2-B]fluorene derivatives and related compounds as materials for organic electroluminescent devices (OLED) OCIAD2, OCIAD1, JUND TDP1 1461/4885L3MBTL1 1006/4885ABCG2 1560/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback